We all know about Alzheimer’s Disease, in fact, many of us know someone who has been impacted by it. But there is another ...

The S.E.C. alleged shortcomings in research said to support the drug, and its developer agreed to a $40 million settlement.

A peptide inhibitor called RI-AG03 targets major aggregation “hot spots” of tau proteins, believed to be a key driver of ...

Monash University researchers are assessing a new drug that could be a game changer for the dementia that has struck US actor Bruce Willis, and ...

Researchers believe their work will have a significant impact on drug discovery efforts in the field of neurodegenerative ...

Unlike other types of dementia, such as Alzheimer’s Disease, there are no treatments; but a new drug — sodium selenate — was shown to be safe and well tolerated in people living with bvFTD, as ...

AG03, developed by researchers at the University of Southampton, targets two critical regions of the tau protein linked to ...

Managing dementia in the complex landscape of neurological disorders stands out as a formidable challenge, affecting millions ...

Lewy Body Dementia is progressive, and causes uncontrollable tremors, problems with memory, attention, and sleep.

Tau proteins help to stabilise the internal skeleton of nerve cells (neurons) in the brain. But in Alzheimer’s disease, these ...

In people with Alzheimer's disease, they clump together, starve brain cells of nutrients and slow down signals in the organ ...